Abstract
Enteroviruses (EVs) are common and significant human pathogens in Asia. EV infections can cause a wide spectrum of acute diseases, including CNS complications. These EV infection-related CNS syndromes include acute flaccid paralysis, aseptic meningitis, encephalitis, and even death. Currently, there is no vaccine available for most EVs except for poliovirus; furthermore, there is a lack of clinical antiviral drugs for treating EV-related infections. These shortages reveal the need to develop potent compounds for treating enteroviral infections. This study summarizes the development of drugs for EV-related infections based on molecular targets blocking various steps in the viral replication cycle.
Keywords: Enterovirus, antiviral agent, therapy, inhibition, viral encephalitis, capsid inhibitor, protease inhibitor, polymerase inhibitor, CNS complications, EV infection-related CNS syndromes, acute flaccid paralysis, aseptic meningitis, encephalitis, poliovirus, viral replication cycle
Infectious Disorders - Drug Targets
Title: Drug Discovery in Enteroviral Infections
Volume: 11 Issue: 3
Author(s): Tzu-Chun Chen and Shin-Ru Shih
Affiliation:
Keywords: Enterovirus, antiviral agent, therapy, inhibition, viral encephalitis, capsid inhibitor, protease inhibitor, polymerase inhibitor, CNS complications, EV infection-related CNS syndromes, acute flaccid paralysis, aseptic meningitis, encephalitis, poliovirus, viral replication cycle
Abstract: Enteroviruses (EVs) are common and significant human pathogens in Asia. EV infections can cause a wide spectrum of acute diseases, including CNS complications. These EV infection-related CNS syndromes include acute flaccid paralysis, aseptic meningitis, encephalitis, and even death. Currently, there is no vaccine available for most EVs except for poliovirus; furthermore, there is a lack of clinical antiviral drugs for treating EV-related infections. These shortages reveal the need to develop potent compounds for treating enteroviral infections. This study summarizes the development of drugs for EV-related infections based on molecular targets blocking various steps in the viral replication cycle.
Export Options
About this article
Cite this article as:
Chen Tzu-Chun and Shih Shin-Ru, Drug Discovery in Enteroviral Infections, Infectious Disorders - Drug Targets 2011; 11 (3) . https://dx.doi.org/10.2174/187152611795768060
DOI https://dx.doi.org/10.2174/187152611795768060 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Proteasomal Pathways by Dietary Curcumin for Cancer Prevention and Treatment
Current Medicinal Chemistry Impairment of T Cell Immunity by the Respiratory Syncytial Virus: Targeting Virulence Mechanisms for Therapy and Prophylaxis
Current Medicinal Chemistry Therapeutic Perspectives of Drugs Targeting Toll-Like Receptors Based on Immune Physiopathology Theory of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets The Role of T-Helper Cells in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Assessment of Gene Transfer Using Imaging Methodology
Current Genomics Intrinsic Disorder and Function of the HIV-1 Tat Protein
Protein & Peptide Letters CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
Current Alzheimer Research Using Non-Pharmacological Approaches for CJD Patient and Family Support as Provided by the CJD Foundation and CJD Insight
CNS & Neurological Disorders - Drug Targets Computational Drug Repositioning by Target Hopping: A Use Case in Chagas Disease
Current Pharmaceutical Design Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Sodium Lauryl Sulfate, a Microbicide Effective Against Enveloped and Nonenveloped Viruses
Current Drug Targets Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy Chemotherapy In Japanese Encephalitis: Are We There Yet?
Infectious Disorders - Drug Targets Recent Patents on Epilepsy Genetics
Recent Patents on DNA & Gene Sequences PFGE: Importance in Food Quality
Recent Patents on Food, Nutrition & Agriculture Programmed Symptoms: Disparate Effects United by Purpose
Current Rheumatology Reviews Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines
Letters in Drug Design & Discovery Bridge Between Neuroimmunity and Traumatic Brain Injury
Current Pharmaceutical Design